Evidence map›Paper›PMID 39121932›Full record

ArticleJournal of biomedical informatics2024

A GPT-based EHR modeling system for unsupervised novel disease detection.

Boran Hao, Yang Hu, William G Adams, Sabrina A Assoumou, Heather E Hsu, Nahid Bhadelia, Ioannis Ch Paschalidis

Abstract read
In one paragraph

Article in Journal of biomedical informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Boran HaoDepartment of Electrical and Computer Engineering, Boston University, Boston, MA, USA.
Yang HuDepartment of Electrical and Computer Engineering, Boston University, Boston, MA, USA.
William G AdamsDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA; Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.
Sabrina A AssoumouDepartment of Medicine, Boston Medical Center, Boston, MA, USA; Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.
Heather E HsuDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA; Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.
Nahid BhadeliaChobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA; Center for Emerging Infectious Diseases Policy and Research, Boston University, Boston, MA, USA.
Ioannis Ch PaschalidisDepartment of Electrical and Computer Engineering, Boston University, Boston, MA, USA; Department of Biomedical Engineering, Division of Systems Engineering, Faculty of Computing & Data Sciences, and Hariri Institute for Computing and Computational Science & Engineering, Boston University, Boston, MA, USA. Electronic address: yannisp@bu.edu.

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Boston University Clinical and Translational Science Institute - U ProgramU54TR001012 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CENTER, DAVID M. · 2014 to 2014
$3.9M
NCATS NIH HHS U54 TR001012NCATS NIH HHS UL1 TR001430NIH HHS UL54 TR004130
6 · The paper itself

Abstract

objectiveTo develop an Artificial Intelligence (AI)-based anomaly detection model as a complement of an "astute physician" in detecting novel disease cases in a hospital and preventing emerging outbreaks.

methodsData included hospitalized patients (n = 120,714) at a safety-net hospital in Massachusetts. A novel Generative Pre-trained Transformer (GPT)-based clinical anomaly detection system was designed and further trained using Empirical Risk Minimization (ERM), which can model a hospitalized patient's Electronic Health Records (EHR) and detect atypical patients. Methods and performance metrics, similar to the ones behind the recent Large Language Models (LLMs), were leveraged to capture the dynamic evolution of the patient's clinical variables and compute an Out-Of-Distribution (OOD) anomaly score.

resultsIn a completely unsupervised setting, hospitalizations for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection could have been predicted by our GPT model at the beginning of the COVID-19 pandemic, with an Area Under the Receiver Operating Characteristic Curve (AUC) of 92.2 %, using 31 extracted clinical variables and a 3-day detection window. Our GPT achieves individual patient-level anomaly detection and mortality prediction AUC of 78.3 % and 94.7 %, outperforming traditional linear models by 6.6 % and 9 %, respectively. Different types of clinical trajectories of a SARS-CoV-2 infection are captured by our model to make interpretable detections, while a trend of over-pessimistic outcome prediction yields a more effective detection pathway. Furthermore, our comprehensive GPT model can potentially assist clinicians with forecasting patient clinical variables and developing personalized treatment plans.

conclusionThis study demonstrates that an emerging outbreak can be accurately detected within a hospital, by using a GPT to model patient EHR time sequences and labeling them as anomalous when actual outcomes are not supported by the model. Such a GPT is also a comprehensive model with the functionality of generating future patient clinical variables, which can potentially assist clinicians in developing personalized treatment plans.

Indexed as

COVID-19Electronic Health RecordsAlgorithmsArtificial IntelligenceFemaleHospitalizationHumansMaleMassachusettsMiddle AgedPandemicsROC CurveSARS-CoV-2Deep learningEHR modelingGPTNovel disease detectionPandemic prevention

Identifiers

PMID39121932
PMCPMC12067473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.